Table 2

Incidence of retinopathy of prematurity (ROP) and frequency of treatment in relation to gestational age (GA)

GA (weeks)21/22* n=8723 n=26024 n=42925 n=58926 n=77427 n=89128 n=113429 n=140430 n=1681Total n=7249
ROP stage, n (%)
 09 (10.3)26 (10.0)72 (16.8)155 (26.3)349 (45.1)606 (68.0)907 (80.0)1225 (87.3)1590 (94.6)4939 (68.1)
 15 (5.7)26 (10.0)54 (12.6)93 (15.8)105 (13.6)118 (13.2)116 (10.2)95 (6.8)58 (3.5)670 (9.2)
 216 (18.4)57 (21.9)109 (25.4)178 (30.2)184 (23.8)118 (13.2)79 (7.0)66 (4.7)23 (1.4)830 (11.4)
 354 (62.1)143 (55.0)183 (42.7)158 (26.8)135 (17.4)48 (5.4)32 (2.8)17 (1.2)10 (0.6)780 (10.8)
 41 (1.1)1 (0.4)4 (0.9)1 (0.2)0 (0.0)1 (0.1)0 (0.0)0 (0.0)0 (0.0)8 (0.1)
 52 (2.3)7 (2.7)7 (1.6)4 (0.7)1 (0.1)0 (0.0)0 (0.0)1 (0.1)0 (0.0)22 (0.3)
Treated ROP,n (%)43 (49.4)109 (41.9)120 (28.0)83 (14.1)58 (7.5)14 (1.6)9 (0.8)4 (0.3)0 (0.0)440 (6.1)
  • * There were two infants born at 21 weeks, both developed ROP stage 3 and were treated for ROP.